Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 05, 2021 at 05:23 am
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 277.529 million compared to CNY 237.153 million a year ago. Operating income was CNY 46.994 million compared to CNY 47.860 million a year ago. Net income was CNY 42.529 million compared to CNY 41.739 million a year ago. Basic earnings per share from continuing operations was CNY 0.2066 compared to CNY 0.2028 a year ago. Diluted earnings per share from continuing operations was CNY 0.1888 compared to CNY 0.2028 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
